Filtered By:
Source: Cardiology Journal

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 265 results found since Jan 2013.

Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis
CONCLUSIONS: Among HBR patients implanted with new-generation DES, short DAPT was associated with reduced risk of major bleeding without significantly increasing the risk of definite or probable ST and MI in comparison with standard DAPT.PMID:35912712 | DOI:10.5603/CJ.a2022.0071
Source: Cardiology Journal - August 1, 2022 Category: Cardiology Authors: Yan Han Xiaohang Yuan Xin Hu Yan Fang Mengting Jiang Huanhuan Feng Lei Gao Source Type: research

Silent cerebral infarcts in patients with atrial fibrillation: Clinical implications of an imaging-adjusted CHA2DS2-VASc score
CONCLUSIONS: Incorporation of silent infarcts into the CHA₂DS₂-VASc score may change the risk-benefit ratio of anticoagulation. It may also increase the number of patients who would benefit from periprocedural bridging. Future research should examine whether an anticoagulation strategy based on imaging-adjusted CHA₂DS₂-VASc scores could result in a greater reduction of stroke and cognitive decline.PMID:35703042 | DOI:10.5603/CJ.a2022.0055
Source: Cardiology Journal - June 15, 2022 Category: Cardiology Authors: John P Bretzman Andrew S Tseng Jonathan Graff-Radford Hon-Chi Lee Samuel J Asirvatham Michelle M Mielke David S Knopman Ronald C Petersen Clifford R Jack Prashanthi Vemuri Alejandro A Rabinstein Christopher V DeSimone Source Type: research

Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study
CONCLUSIONS: In clinical practice, AF patients anticoagulated with rivaroxaban exhibit a low risk of events. 2MACE score acts as a modest predictor of a higher risk of adverse outcomes in this population. 2MACER did not significantly increase the ability of 2MACE to predict MACE.PMID:35621092 | DOI:10.5603/CJ.a2022.0044
Source: Cardiology Journal - May 27, 2022 Category: Cardiology Authors: Marcelo Sanmart ín Fernández Manuel Anguita S ánchez Fernando Arribas Gonzalo Bar ón-Esquivias Vivencio Barrios Juan Cosin-Sales Mar ía Asunción Esteve-Pastor Roman Freixa-Pamias I ñaki Lekuona Alejandro I P érez-Cabeza Isabel Ure ña Jos é Manue Source Type: research